Follow
Samuel B. Anyona
Samuel B. Anyona
Other namesSamuel Anyona
Verified email at maseno.ac.ke
Title
Cited by
Cited by
Year
Impact of RTS,S/AS02A and RTS,S/AS01B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial
JN Waitumbi, SB Anyona, CW Hunja, CM Kifude, ME Polhemus, ...
PLoS One 4 (11), e7849, 2009
662009
Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western Kenya
EO Onyango, G Ayodo, CA Watsierah, T Were, W Okumu, SB Anyona, ...
BMC infectious diseases 12, 1-11, 2012
602012
Outpatient upper respiratory tract viral infections in children with malaria symptoms in Western Kenya
JN Waitumbi, J Kuypers, SB Anyona, JN Koros, ME Polhemus, J Gerlach, ...
The American journal of tropical medicine and hygiene 83 (5), 1010, 2010
472010
Functional haplotypes of Fc gamma (Fcγ) receptor (FcγRIIA and FcγRIIIB) predict risk to repeated episodes of severe malarial anemia and mortality in Kenyan children
C Ouma, GC Davenport, S Garcia, P Kempaiah, A Chaudhary, T Were, ...
Human genetics 131, 289-299, 2012
352012
Association between Fcγ receptor IIA, IIIA and IIIB genetic polymorphisms and susceptibility to severe malaria anemia in children in western Kenya
EO Munde, WA Okeyo, E Raballah, SB Anyona, T Were, JM Ong’echa, ...
BMC infectious diseases 17, 1-10, 2017
272017
Pitting of malaria parasites and spherocyte formation
SB Anyona, SL Schrier, CW Gichuki, JN Waitumbi
Malaria journal 5, 1-8, 2006
272006
Malaria prevalence defined by microscopy, antigen detection, DNA amplification and total nucleic acid amplification in a malaria‐endemic region during the peak malaria …
JN Waitumbi, J Gerlach, I Afonina, SB Anyona, JN Koros, J Siangla, ...
Tropical Medicine & International Health 16 (7), 786-793, 2011
252011
Direct detection of bacteremia by exploiting host-pathogen interactions of lipoteichoic acid and lipopolysaccharide
JZ Kubicek-Sutherland, DM Vu, A Noormohamed, HM Mendez, ...
Scientific reports 9 (1), 6203, 2019
232019
Functional promoter haplotypes of interleukin-18 condition susceptibility to severe malarial anemia and childhood mortality
SB Anyona, P Kempaiah, E Raballah, C Ouma, T Were, GC Davenport, ...
Infection and immunity 79 (12), 4923-4932, 2011
222011
Polymorphic variability in the 3'untranslated region (UTR) of IL12B is associated with susceptibility to severe anaemia in Kenyan children with acute Plasmodium falciparum malaria
JM Ong'echa, EO Raballah, PM Kempaiah, SB Anyona, T Were, ...
BMC genetics 12, 1-9, 2011
212011
Polymorphisms in the Fc gamma receptor IIIA and toll-like receptor 9 are associated with protection against severe malarial anemia and changes in circulating gamma interferon …
EO Munde, WA Okeyo, SB Anyona, E Raballah, S Konah, W Okumu, ...
Infection and immunity 80 (12), 4435-4443, 2012
202012
Reduced systemic bicyclo‐prostaglandin‐E2 and cyclooxygenase‐2 gene expression are associated with inefficient erythropoiesis and enhanced uptake of …
SB Anyona, P Kempaiah, E Raballah, GC Davenport, T Were, SN Konah, ...
American journal of hematology 87 (8), 782-789, 2012
202012
Changes in the frequencies of Plasmodium falciparum dhps and dhfr drug-resistant mutations in children from Western Kenya from 2005 to 2018: the rise of Pfdhps S436H
MA Pacheco, KA Schneider, Q Cheng, EO Munde, C Ndege, C Onyango, ...
Malaria Journal 19, 1-9, 2020
192020
Reduced interferon (IFN)-α conditioned by IFNA2 (−173) and IFNA8 (−884) haplotypes is associated with enhanced susceptibility to severe malarial anemia and …
P Kempaiah, SB Anyona, E Raballah, GC Davenport, T Were, JB Hittner, ...
Human genetics 131, 1375-1391, 2012
192012
Cyclooxygenase-2 haplotypes influence the longitudinal risk of malaria and severe malarial anemia in Kenyan children from a holoendemic transmission region
SB Anyona, NW Hengartner, E Raballah, JM Ong’echa, N Lauve, ...
Journal of human genetics 65 (2), 99-113, 2020
152020
Suppressed circulating bicyclo-PGE2 levels and leukocyte COX-2 transcripts in children co-infected with P. falciparum malaria and HIV-1 or bacteremia
SB Anyona, P Kempaiah, GC Davenport, JM Vulule, JB Hittner, ...
Biochemical and biophysical research communications 436 (4), 585-590, 2013
142013
Integrated OMICS platforms identify LAIR1 genetic variants as novel predictors of cross-sectional and longitudinal susceptibility to severe malaria and all-cause mortality in …
AO Achieng, NW Hengartner, E Raballah, Q Cheng, SB Anyona, N Lauve, ...
EBioMedicine 45, 290-302, 2019
132019
Interleukin (IL)-13 promoter polymorphisms (-7402 T/G and-4729G/A) condition susceptibility to pediatric severe malarial anemia but not circulating IL-13 levels
WA Okeyo, EO Munde, W Okumu, E Raballah, SB Anyona, JM Vulule, ...
BMC immunology 14, 1-8, 2013
122013
Genetic variation in interleukin-7 is associated with a reduced erythropoietic response in Kenyan children infected with Plasmodium falciparum
LE Kisia, P Kempaiah, SB Anyona, EO Munde, AO Achieng, JM Ong’echa, ...
BMC Medical Genetics 20, 1-10, 2019
102019
The global Burden of severe falciparum malaria: an immunological and genetic perspective on pathogenesis
DJ Perkins, T Were, S Anyona, JB Hittner, P Kempaiah, GC Davenport, ...
Dynamic Models of Infectious Diseases: Volume 1: Vector-Borne Diseases, 231-283, 2013
82013
The system can't perform the operation now. Try again later.
Articles 1–20